An estrogen receptor antagonist, Fulvestrant is used for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women. It is administered intramuscularly. Reference standards of Fulvestrant API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Fulvestrant-3-glucuronide lithium salt [catalogue_number] => PA 06 0541021 [category_ids] => ,70,75,76,78,82,95, [chemical_name] => [weight] => 788.83 [form] => C38H54F5LiO9S [cas] => NA [pslug] => fulvestrant-3-glucuronide-lithium-salt-pa060541021 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 06 0541021
CAS :
Molecular Formula : C38H54F5LiO9S
Molecular Weight : 788.83
stdClass Object ( [pname] => Fulvestrant-3-Glucuronide [catalogue_number] => PA 06 0541031 [category_ids] => ,70,75,76,78,82,95, [chemical_name] => [weight] => 782.9 [form] => C38H55F5O9S [cas] => 261506-27-8 [pslug] => 261506-27-8-fulvestrant-3-glucuronide-pa060541031 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 06 0541031
Molecular Formula : C38H55F5O9S
Molecular Weight : 782.9
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
